Trials / Completed
CompletedNCT01740687
A Study to Evaluate the Effectiveness of Essure Post-NovaSure Radiofrequency Endometrial Ablation Procedure Following a Successful Essure Confirmation Test
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 211 (actual)
- Sponsor
- Bayer · Industry
- Sex
- Female
- Age
- 21 Years – 50 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of the post approval study is to evaluate the effectiveness and safety of the Essure System when a NovaSure Endometrial Ablation procedure is performed following a successful Essure Confirmation Test.
Detailed description
This study has previously been posted by Conceptus, Inc. After acquiring Conceptus, Inc., Bayer is now the sponsor of the trial.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | ESS305 (Essure, BAY1454032) | Essure Permanent Birth Control |
| PROCEDURE | NovaSure | Nova Sure Endometrial Ablation |
Timeline
- Start date
- 2012-11-13
- Primary completion
- 2021-05-17
- Completion
- 2021-06-14
- First posted
- 2012-12-04
- Last updated
- 2023-02-06
- Results posted
- 2023-02-06
Locations
17 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT01740687. Inclusion in this directory is not an endorsement.